Altered vitamin D metabolism in type II diabetic mouse glomeruli may provide protection from diabetic nephropathy

Y Wang1, J Zhou, A W Minto

  • 1Department of Medicine, The University of Chicago, Chicago, Illinois 60637, USA.

Insights

Vitamin D metabolism is altered in diabetic mice (db/db), with increased vitamin D activity in the kidneys. This may protect against diabetic kidney disease by influencing podocyte function.

Area of Science:

  • Nephrology
  • Endocrinology
  • Molecular Biology

Background:

  • Type II diabetes mellitus in db/db mice exhibits metabolic features but less severe renal disease than in humans.
  • Evidence suggests a role for vitamin D in human diabetes.
  • Investigating vitamin D's role in diabetic nephropathy in db/db mice is crucial.

Purpose of the Study:

  • To investigate alterations in vitamin D metabolism and homeostasis in the kidneys of db/db mice.
  • To determine the effect of high glucose on vitamin D-related gene expression and protein production in cultured podocytes.
  • To explore the potential protective role of vitamin D in diabetic nephropathy.

Main Methods:

  • Transcriptional profiling of glomeruli from db/db mice and non-diabetic db/+ littermates.
  • Quantitative reverse transcription-polymerase chain reaction (RT-PCR) to confirm gene expression.
  • Immunohistochemistry to assess protein localization.
  • Measurement of serum vitamin D metabolites and urinary calcium excretion.
  • In vitro studies using cultured glomerular podocytes exposed to high glucose.

Main Results:

  • db/db mice showed significant upregulation of genes involved in calcium (Ca2+) homeostasis and vitamin D metabolism in glomeruli.
  • Increased glomerular expression of key vitamin D pathway genes (e.g., vitamin D3 1alpha-hydroxylase, vitamin D binding protein, calbindins) was confirmed.
  • Elevated serum 1,25-dihydroxyvitamin D3 and urinary Ca2+ excretion were observed in db/db mice.
  • High glucose increased fibronectin and collagen IV production in cultured podocytes, an effect blocked by 1,25-dihydroxyvitamin D3.
  • Vitamin D3 1alpha-hydroxylase was expressed in glomerular podocytes and upregulated in renal tubules of db/db mice.

Conclusions:

  • Vitamin D metabolism is significantly altered in db/db mice, with increased activity in the kidneys.
  • The podocyte is a target for vitamin D, potentially via paracrine and autocrine mechanisms.
  • Vitamin D may play a protective role against progressive diabetic nephropathy in db/db mice, explaining their resistance.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...